Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists

被引：0
|
作者：
Shellie D. Ellis
Soohyun Hwang
Emily Morrow
Kim S. Kimminau
Kelly Goonan
Laurie Petty
Edward Ellerbeck
J. Brantley Thrasher
机构：
[1] University of Kansas,Department of Population Health, School of Medicine
[2] University of North Carolina Chapel Hill,Department of Health Policy and Management, School of Public Health
[3] University of Kansas,Department of Sociology
[4] University of Kansas,Department of Family Medicine, School of Medicine
[5] Independent Researcher/Consultant/Scientific Writer,undefined
[6] American Board of Urology,undefined
来源：
BMC Cancer | / 21卷
关键词：
Active surveillance; Prostate cancer; Adoption; Barriers; Low-risk disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features
    Suardi, Nazareno
    Capitanio, Umberto
    Chun, Felix K. H.
    Graefen, Markus
    Perrotte, Paul
    Schlomm, Thorsten
    Haese, Alexander
    Huland, Hartwig
    Erbersdobler, Andreas
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    CANCER, 2008, 113 (08) : 2068 - 2072
  • [32] A Decision Analysis Comparing 3 Active Surveillance Protocols for the Treatment of Patients With Low-Risk Prostate Cancer
    White, Craig
    Nimeh, Tony
    Gazelle, G. Scott
    Weinstein, Milton C.
    Loughlin, Kevin R.
    CANCER, 2019, 125 (06) : 952 - 962
  • [33] Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study
    Chen, Jason C.
    Subramanian, Lalita
    Skolarus, Ted A.
    Hawley, Sarah T.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Borza, Tudor
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025, : 1107 - 1115
  • [34] Evolving indications for active surveillance in low-risk localized prostate cancer
    Carroll, PR
    Cooperberg, MR
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (09) : 7 - 13
  • [35] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [36] Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)
    Klaus Eredics
    Karl Dorfinger
    Gero Kramer
    Anton Ponholzer
    Stephan Madersbacher
    Wiener klinische Wochenschrift, 2017, 129 : 375 - 379
  • [37] Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review
    Perera, Sachin
    McDonald, Jodie
    Williams, Isabella
    O'Brien, Jonathan
    Murphy, Declan
    Lawrentschuk, Nathan
    PROSTATE INTERNATIONAL, 2022, 10 (03) : 117 - 122
  • [38] Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018
    Briganti, Alberto
    Fossati, Nicola
    Catto, James W. F.
    Cornford, Philip
    Montorsi, Francesco
    Mottet, Nicolas
    Wirth, Manfred
    Van Poppel, Hendrik
    EUROPEAN UROLOGY, 2018, 74 (03) : 357 - 368
  • [39] Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives
    Zhu, Pingting
    Zhang, Qianqian
    Wu, Qiwei
    Shi, Guanghui
    Wang, Wen
    Xu, Huiwen
    Zhang, Li
    Qian, Meiyan
    Hegarty, Josephine
    THYROID, 2023, 33 (07) : 826 - 834
  • [40] Active surveillance in low risk prostate cancer
    Bozkurt, Ozan
    Demir, Omer
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 76 - 79
12345